Clover Health Investments, Corp.
CLOV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 8.8% | 15% | -25.5% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $2 |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 26.6% | 20.3% | 9.4% | -5.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $1 |
| Operating Income | -$0 | -$0 | -$0 | -$1 |
| % Margin | -3.3% | -16.3% | -26.1% | -43.3% |
| Other Income/Exp. Net | -$0 | -$0 | $0 | $0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 | -$1 |
| % Margin | -3.1% | -16.9% | -31% | -39.9% |
| EPS | -0.088 | -0.45 | -0.71 | -1.25 |
| % Growth | 80.5% | 36.6% | 43.2% | – |
| EPS Diluted | -0.088 | -0.45 | -0.71 | -1.25 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | -$1 |
| % Margin | -3.3% | -16.5% | -23% | -38.7% |